Pathologic conditions of the toenail are defined in Box 11-3, and terms describing infections are defined in Box 11-4
In recent years, GLP-1 approvals have expanded beyond blood sugar management and weight loss to include other organs, like the heart, kidneys, and liver
However, these agents can be expensive for patients whose insurances do not cover the medications
A 2023 study published in Molecular Psychiatry found that GLP-1 receptor knockout mice displayed hyperactivity, impulsivity, and reduced sustained attention
Stanley CA: Carnitine deficiency disorders in children
Women who should avoid PT-141 or only use it under close medical supervision include those with: Uncontrolled hypertension Significant cardiovascular disease Known hypersensitivity to melanocortin peptides A history of severe adverse reactions to injectable therapies Pregnancy or breastfeeding PT-141 can cause temporary increases in blood pressure shortly after administration, which is why cardiovascular screening is an important part of the evaluation process
